Companies / Gritstone Oncology, Inc.
Gritstone Oncology, Inc.
GRTSCIK 1656634
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 30, 2020 | Woiwode Thomas Director | Buy Open-market buy | Common Stock | $5.00M | +1.3M | 1,347,709 | high |
| Jan 19, 2021 | Rousseau Raphael Executive | Sell Open-market sale | Common Stock | $350.6K | -20K -100.00% | 0 | medium |
| Jan 20, 2021 | Rousseau Raphael Executive | Sell Open-market sale | Common Stock | $250.7K | -10K -100.00% | 0 | medium |
| Jan 19, 2021 | Yelensky Roman Executive | Sell Open-market sale | Common Stock | $221.0K | -10K -5.86% | 160,624 | medium |
| Jan 19, 2021 | Yelensky Roman Executive | Sell Open-market sale | Common Stock | $221.0K | -10K -6.98% | 133,224 | medium |
| Mar 8, 2021 | Yelensky Roman Executive | Exercise Option exercise | Common Stock | $38.5K | +51K +38.07% | 183,948 | low |
| Mar 8, 2021 | Yelensky Roman Executive | Exercise Option exercise | Common Stock | $38.5K | +51K +27.58% | 234,672 | low |
| May 27, 2021 | Rousseau Raphael Executive | Sell Open-market sale | Common Stock | $26.1K | -3K -100.00% | 0 | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| GRTS | common | 39868T105 |